Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Psychooncology. 2020 Feb 25;29(5):841–850. doi: 10.1002/pon.5355

Table 3.

A, Mindfulness group means, standard deviations, and within group changes and B, Waitlist control group means, standard deviations, and within group changes

Paired Samples t-test (Baseline to Week 16)
Domain Outcome measure Baseline (N = 67)
Week 8 (N = 36)
Week 16 (N = 35)
95% CI
Mean (SD) Mean (SD) Mean (SD) t df P Lower Upper
Disease and treatment related symptoms
Pain interference 53.70 (10.58) 51.61 (10.32) 52.35 (11.51) 0.58 34 .566 −3.10 5.58
Fatigue 57.80 (8.14) 54.80 (8.20) 53.57 (9.72) −1.82 34 .078 −5.36 0.30
Sleep disturbance 54.92 (8.21) 51.63 (9.14) 51.48 (7.59) −1.67 34 .103 −4.85 0.47
Psychosocial distress
Anxiety 59.19 (7.54) 57.25 (6.54) 56.96 (8.14) −1.07 34 .290 −6.05 1.86
Depression 53.51 (8.44) 52.84 (7.45) 54.15 (9.23) 0.38 33 .706 −2.91 4.25
Social isolation 49.89 (8.70) 49.70 (9.11) 48.00 (10.05) −0.79 34 .434 −5.68 2.50
Cancer survivor concerns 16.67 (7.47) 16.28 (7.72) 16.71 (8.39) 0.19 33 .848 −2.60 3.14
Perceived stress 7.00 (2.46) 5.86 (2.79) 5.82 (2.52) −1.48 33 .147 −1.81 0.28
Self-judgement 3.28 (0.91) 3.18 (0.93) 3.06 (0.81) −1.95 33 .059 −0.55 0.01
Intolerance of uncertainty 19.41 (7.43) 15.79 (9.88) 15.68 (6.71) −2.70 33 .011* −5.57 −0.78
Overall wellbeing
Emotional support 53.53 (8.71) 54.49 (8.82) 54.85 (7.26) 1.13 34 .267 −1.10 3.84
Role satisfaction 48.45 (8.91) 50.84 (8.67) 50.07 (6.94) 0.36 34 .719 −2.66 3.81
Positive affect and wellbeing 50.75 (6.36) 52.35 (6.51) 53.25 (5.72) 1.72 34 .094 −0.28 3.32
Mindful attention and awareness 3.88 (0.88) 3.65 (0.82) 3.91 (0.93) 0.85 33 .403 −0.19 0.46
Post-traumatic growth 3.24 (1.16) 3.39 (1.21) 3.66 (0.94) 2.40 33 .022* 0.06 0.78
Self-kindness 3.17 (0.72) 3.18 (0.74) 3.51 (0.58) 3.95 33 <.001* 0.22 0.69
Paired Samples t-test (Baseline to Week 16)
Domain Outcome measure Baseline (N = 67)
Week 8 (N = 36)
Week 16 (N = 35)
95% CI
Mean (SD) Mean (SD) Mean (SD) t df P Lower Upper
Disease and treatment related symptoms
Pain interference 53.13 (10.32) 51.37 (9.09) 53.08 (9.63) −0.50 41 .622 −4.43 2.68
Fatigue 55.61 (8.20) 55.03 (8.47) 54.18 (9.03) −1.16 41 .254 −3.47 0.94
Sleep disturbance 51.84 (9.14) 51.92 (8.98) 51.19 (7.42) −1.51 41 .139 −4.17 0.61
Psychosocial distress
Anxiety 59.17 (6.54) 58.76 (6.38) 57.38 (7.94) −1.78 41 .083 −3.84 0.25
Depression 54.95 (7.45) 54.58 (7.36) 53.65 (8.15) −3.01 41 .004* −4.73 −0.94
Social isolation 50.75 (9.11) 51.92 (7.96) 52.05 (8.41) 0.47 41 .644 −1.92 3.06
Cancer survivor concerns 16.44 (7.72) 17.32 (8.49) 17.43 (7.45) 0.45 41 .657 −1.57 2.46
Perceived Stress 7.31 (2.79) 6.65 (2.83) 6.55 (2.82) −2.30 41 .026* −2.01 −0.13
Self-judgement 3.18 (0.93) 3.29 (0.91) 3.16 (0.96) −0.95 41 .350 −0.32 0.12
Intolerance of uncertainty 19.91 (9.88) 18.43 (9.08) 16.67 (8.21) −2.83 41 .007* −5.90 −0.99
Overall wellbeing
Emotional support 52.17 (8.82) 51.50 (8.51) 51.37 (9.02) −0.90 41 .376 −3.06 3.06
Role satisfaction 47.91 (8.67) 49.56 (8.88) 49.03 (10.24) 0.74 41 .464 −1.91 4.12
Positive affect and wellbeing 51.11 (6.51) 51.59 (6.44) 51.96 (7.05) 1.48 41 .147 −0.52 3.36
Mindful attention and awareness 4.12 (0.82) 3.98 (0.76) 4.00 (1.04) −0.60 41 .554 −0.24 0.13
Post-traumatic growth 3.01 (1.21) 3.17 (1.27) 3.07 (1.26) 0.77 41 .446 −0.19 0.42
Self-kindness 3.22 (0.74) 3.19 (0.76) 3.22 (0.73) −0.05 41 .962 −0.20 0.19